Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 26 05 2021
accepted: 15 09 2021
entrez: 2 10 2021
pubmed: 3 10 2021
medline: 21 10 2021
Statut: epublish

Résumé

Distinct SARS-CoV-2 lineages, discovered through various genomic surveillance initiatives, have emerged during the pandemic following unprecedented reductions in worldwide human mobility. We here describe a SARS-CoV-2 lineage - designated B.1.620 - discovered in Lithuania and carrying many mutations and deletions in the spike protein shared with widespread variants of concern (VOCs), including E484K, S477N and deletions HV69Δ, Y144Δ, and LLA241/243Δ. As well as documenting the suite of mutations this lineage carries, we also describe its potential to be resistant to neutralising antibodies, accompanying travel histories for a subset of European cases, evidence of local B.1.620 transmission in Europe with a focus on Lithuania, and significance of its prevalence in Central Africa owing to recent genome sequencing efforts there. We make a case for its likely Central African origin using advanced phylogeographic inference methodologies incorporating recorded travel histories of infected travellers.

Identifiants

pubmed: 34599175
doi: 10.1038/s41467-021-26055-8
pii: 10.1038/s41467-021-26055-8
pmc: PMC8486757
doi:

Substances chimiques

Antibodies, Neutralizing 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5769

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2021. The Author(s).

Références

J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
Curr Protoc. 2021 Apr;1(4):e98
pubmed: 33836121
Syst Biol. 2012 May;61(3):539-42
pubmed: 22357727
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Bioinformatics. 2021 Jan 20;:
pubmed: 33471068
Viruses. 2020 Aug 15;12(8):
pubmed: 32824272
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
Nat Commun. 2020 Oct 9;11(1):5110
pubmed: 33037213
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Syst Biol. 2016 Mar;65(2):250-64
pubmed: 26526428
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
Nat Microbiol. 2021 Aug;6(8):1094-1101
pubmed: 34163035
Lancet Infect Dis. 2021 Apr;21(4):e80
pubmed: 32791042
Wellcome Open Res. 2020 Mar 30;5:53
pubmed: 32923688
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
BMJ Open. 2020 Aug 5;10(8):e039856
pubmed: 32759252
J Infect Dis. 2014 Jul 1;210(1):121-5
pubmed: 24446525
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Cell. 2019 Aug 22;178(5):1057-1071.e11
pubmed: 31442400
Mol Biol Evol. 2013 Mar;30(3):713-24
pubmed: 23180580
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Cell Host Microbe. 2021 May 12;29(5):747-751.e4
pubmed: 33887205
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Mol Evol. 1994 Sep;39(3):306-14
pubmed: 7932792
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Sci Rep. 2021 Feb 22;11(1):4320
pubmed: 33619331
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638

Auteurs

Gytis Dudas (G)

Gothenburg Global Biodiversity Centre, Gothenburg, Sweden. gytisdudas@gmail.com.
Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania. gytisdudas@gmail.com.

Samuel L Hong (SL)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

Barney I Potter (BI)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

Sébastien Calvignac-Spencer (S)

Epidemiology of Highly Pathogenic Organisms, Robert Koch Institute, 13353, Berlin, Germany.
Viral Evolution, Robert Koch Institute, 13353, Berlin, Germany.

Frédéric S Niatou-Singa (FS)

WWF Central African Republic Programme Office, Dzanga Sangha Protected Areas, BP 1053, Bangui, Central African Republic.

Thais B Tombolomako (TB)

WWF Central African Republic Programme Office, Dzanga Sangha Protected Areas, BP 1053, Bangui, Central African Republic.

Terence Fuh-Neba (T)

WWF Central African Republic Programme Office, Dzanga Sangha Protected Areas, BP 1053, Bangui, Central African Republic.

Ulrich Vickos (U)

Infectious and Tropical Diseases Unit, Department of medicine, Amitié Hospital, Bangui, Central African Republic.
Academic Department of Pediatrics, Clinical immunology and vaccinology, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy.

Markus Ulrich (M)

Epidemiology of Highly Pathogenic Organisms, Robert Koch Institute, 13353, Berlin, Germany.

Fabian H Leendertz (FH)

Epidemiology of Highly Pathogenic Organisms, Robert Koch Institute, 13353, Berlin, Germany.

Kamran Khan (K)

BlueDot, Toronto, ON, M5J 1A7, Canada.
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, M5B 1A6, Canada.
Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, M5S 3H2, Canada.

Carmen Huber (C)

BlueDot, Toronto, ON, M5J 1A7, Canada.

Alexander Watts (A)

BlueDot, Toronto, ON, M5J 1A7, Canada.

Ingrida Olendraitė (I)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital Lab, CB2 2QQ, Cambridge, UK.

Joost Snijder (J)

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.

Kim N Wijnant (KN)

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.

Alexandre M J J Bonvin (AMJJ)

Bijvoet Centre for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.

Pascale Martres (P)

Microbiology, Centre Hospitalier René Dubos, Cergy Pontoise, France.

Sylvie Behillil (S)

Molecular Genetics of RNA viruses, CNRS UMR 3569, Université de Paris, Institut Pasteur, Paris, France.
National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.

Ahidjo Ayouba (A)

TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, 34394, Montpellier cedex, France.

Martin Foudi Maidadi (MF)

Centre de Recherches sur les Maladies Émergentes, Ré-émergentes et la Médecine Nucléaire, Institut de Recherches Médicales et D'études des Plantes Médicinales, Yaoundé, Cameroon.

Dowbiss Meta Djomsi (DM)

Centre de Recherches sur les Maladies Émergentes, Ré-émergentes et la Médecine Nucléaire, Institut de Recherches Médicales et D'études des Plantes Médicinales, Yaoundé, Cameroon.

Celestin Godwe (C)

Centre de Recherches sur les Maladies Émergentes, Ré-émergentes et la Médecine Nucléaire, Institut de Recherches Médicales et D'études des Plantes Médicinales, Yaoundé, Cameroon.

Christelle Butel (C)

TransVIHMI, Université de Montpellier, IRD, INSERM, 911 Avenue Agropolis, 34394, Montpellier cedex, France.

Aistis Šimaitis (A)

The Office of the Government of the Republic of Lithuania, Vilnius, Lithuania.

Miglė Gabrielaitė (M)

Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.

Monika Katėnaitė (M)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Rimvydas Norvilas (R)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Department of Experimental, Preventive and Clinical Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.

Ligita Raugaitė (L)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Giscard Wilfried Koyaweda (GW)

Le Laboratoire National de Biologie Clinique et de Santé Publique (LNBCSP), Bangui, Central African Republic.

Jephté Kaleb Kandou (JK)

Le Laboratoire National de Biologie Clinique et de Santé Publique (LNBCSP), Bangui, Central African Republic.

Rimvydas Jonikas (R)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.

Inga Nasvytienė (I)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.

Živilė Žemeckienė (Ž)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.

Dovydas Gečys (D)

Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Kamilė Tamušauskaitė (K)

Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Milda Norkienė (M)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Emilija Vasiliūnaitė (E)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Danguolė Žiogienė (D)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Albertas Timinskas (A)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Marius Šukys (M)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Mantas Šarauskas (M)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.

Gediminas Alzbutas (G)

Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Adrienne Amuri Aziza (AA)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Eddy Kinganda Lusamaki (EK)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Jean-Claude Makangara Cigolo (JM)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Francisca Muyembe Mawete (FM)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Emmanuel Lokilo Lofiko (EL)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.

Placide Mbala Kingebeni (PM)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Jean-Jacques Muyembe Tamfum (JM)

National Institute for Biomedical Research (INRB), Avenue De la Democratie (Ex Huileries), BP 1197, Kinshasa-Gombe, Democratic Republic of the Congo.
University of Kinshasa (UNIKIN), BP 127, Kinshasa XI, Democratic Republic of the Congo.

Marie Roseline Darnycka Belizaire (MRD)

World Health Organization, Central African Republic Office, Bangui, Central African Republic.

René Ghislain Essomba (RG)

National Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Marie Claire Okomo Assoumou (MCO)

National Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Akenji Blaise Mboringong (AB)

National Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon.

Alle Baba Dieng (AB)

World Health Organization, Cameroon Office, Yaoundé, Cameroon.

Dovilė Juozapaitė (D)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Salome Hosch (S)

Swiss Tropical and Public Health Institute, Basel, Switzerland.

Justino Obama (J)

Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.

Mitoha Ondo'o Ayekaba (MO)

Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.

Daniel Naumovas (D)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Arnoldas Pautienius (A)

Institute of Microbiology and Virology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Clotaire Donatien Rafaï (CD)

Le Laboratoire National de Biologie Clinique et de Santé Publique (LNBCSP), Bangui, Central African Republic.

Astra Vitkauskienė (A)

Department of Laboratory Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Rasa Ugenskienė (R)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Alma Gedvilaitė (A)

Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Darius Čereškevičius (D)

Department of Genetics and Molecular Medicine, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Vaiva Lesauskaitė (V)

Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Lukas Žemaitis (L)

Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
National Public Health Surveillance Laboratory, Vilnius, Lithuania.

Laimonas Griškevičius (L)

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Guy Baele (G)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium. guy.baele@kuleuven.be.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH